Panacos Pharmaceuticals (PANC) Hires Oppenheimer & Co. to Review Strategic Alternatives; Reduces Workforce
Tweet Send to a Friend
Panacos Pharmaceuticals, Inc. (NASDAQ: PANC) has engaged Oppenheimer & Co. Inc. to advise the Company on strategic alternatives, which may ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE